Lubman Ellen 4
4 · Werewolf Therapeutics, Inc. · Filed May 4, 2021
Insider Transaction Report
Form 4
Lubman Ellen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2020-08-03+145,531→ 145,531 totalExercise: $1.56Exp: 2030-08-02→ Common Stock (145,531 underlying) - Award
Stock Option (right to buy)
2021-04-30+48,455→ 48,455 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (48,455 underlying) - Award
Stock Option (right to buy)
2020-12-08+118,781→ 118,781 totalExercise: $4.77Exp: 2030-12-07→ Common Stock (118,781 underlying)
Footnotes (3)
- [F1]The option was granted on August 3, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F2]The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F3]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.